Cargando…
Genome-wide association studies of antidepressant class response and treatment-resistant depression
The “antidepressant efficacy” survey (AES) was deployed to > 50,000 23andMe, Inc. research participants to investigate the genetic basis of treatment-resistant depression (TRD) and non-treatment-resistant depression (NTRD). Genome-wide association studies (GWAS) were performed, including TRD vs....
Autores principales: | Li, Qingqin S., Tian, Chao, Hinds, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7589471/ https://www.ncbi.nlm.nih.gov/pubmed/33106475 http://dx.doi.org/10.1038/s41398-020-01035-6 |
Ejemplares similares
-
A genome-wide association study of antidepressant response in Koreans
por: Myung, W, et al.
Publicado: (2015) -
Factors associated with antidepressant responses to repetitive transcranial magnetic stimulation in antidepressant-resistant depression
por: Li, Cheng-Ta, et al.
Publicado: (2022) -
Genome-wide association study and polygenic risk score analysis of esketamine treatment response
por: Li, Qingqin S., et al.
Publicado: (2020) -
The association of clinical phenotypes to known AD/FTD genetic risk loci and their inter-relationship
por: Li, Qingqin S., et al.
Publicado: (2020) -
Antidepressant discontinuation in treatment resistant depression
por: Ali, Ziad A., et al.
Publicado: (2019)